Rhumbline Advisers Landec Corp \Ca\ Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Rhumbline Advisers holds 38,091 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,091

Previous 24,730 54.03%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	N/A	13,361 Added 54.03%	38,091 $0
Q1 2025 Apr 08, 2025	SELL	N/A	-30,993 Reduced 55.62%	24,730 $0
Q4 2024 May 29, 2025	BUY	N/A	30,993 Added 125.33%	55,723 $0
Q4 2024 Jan 30, 2025	BUY	N/A	31,056 Added 125.9%	55,723 $0
Q3 2024 Nov 12, 2024	SELL	N/A	-2,232 Reduced 8.3%	24,667 $0
Q2 2024 Aug 01, 2024	BUY	N/A	25,378 Added 1668.51%	26,899 $0
Q3 2023 Nov 09, 2023	SELL	N/A	-1,637 Reduced 51.84%	1,521 $0
Q2 2023 Aug 08, 2023	SELL	N/A	-38,804 Reduced 92.47%	3,158 $0
Q1 2023 May 11, 2023	BUY	N/A	647 Added 1.57%	41,962 $158,000
Q4 2022 Feb 14, 2023	BUY	$0.0 - $9.95 $0 - $6,109	614 Added 1.51%	41,315 $268,000
Q3 2022 Nov 10, 2022	BUY	$8.57 - $11.57 $24,167 - $32,627	2,820 Added 7.44%	40,701 $362,000
Q2 2022 Aug 11, 2022	BUY	$8.84 - $11.64 $13,003 - $17,122	1,471 Added 4.04%	37,881 $378,000
Q1 2022 May 12, 2022	SELL	$10.07 - $11.93 $31,418 - $37,221	-3,120 Reduced 7.89%	36,410 $422,000
Q4 2021 Feb 10, 2022	SELL	$7.95 - $11.24 $469 - $663	-59 Reduced 0.15%	39,530 $439,000
Q3 2021 Nov 12, 2021	BUY	$9.22 - $12.44 $6,970 - $9,404	756 Added 1.95%	39,589 $365,000
Q2 2021 Aug 05, 2021	SELL	$9.91 - $12.78 $69,924 - $90,175	-7,056 Reduced 15.38%	38,833 $437,000
Q1 2021 May 06, 2021	SELL	$10.44 - $12.22 $1,044 - $1,222	-100 Reduced 0.22%	45,889 $486,000
Q4 2020 Feb 10, 2021	BUY	$9.3 - $11.77 $50,564 - $63,993	5,437 Added 13.41%	45,989 $499,000
Q3 2020 Nov 12, 2020	SELL	$7.59 - $10.8 $46,693 - $66,441	-6,152 Reduced 13.17%	40,552 $394,000
Q2 2020 Aug 13, 2020	BUY	$7.96 - $11.54 $28,464 - $41,267	3,576 Added 8.29%	46,704 $372,000
Q1 2020 May 06, 2020	BUY	$7.69 - $11.68 $12,634 - $19,190	1,643 Added 3.96%	43,128 $375,000
Q4 2019 Feb 05, 2020	BUY	$9.09 - $11.89 $745 - $974	82 Added 0.2%	41,485 $469,000
Q3 2019 Oct 23, 2019	BUY	$9.66 - $12.36 $30,390 - $38,884	3,146 Added 8.22%	41,403 $450,000
Q2 2019 Aug 14, 2019	SELL	$9.32 - $12.98 $9,786 - $13,629	-1,050 Reduced 2.67%	38,257 $358,000
Q1 2019 May 01, 2019	BUY	$10.35 - $13.06 $9,149 - $11,545	884 Added 2.3%	39,307 $483,000
Q4 2018 Jan 31, 2019	BUY	$11.64 - $15.41 $137,258 - $181,714	11,792 Added 44.28%	38,423 $455,000
Q2 2018 Aug 06, 2018	BUY	$13.05 - $15.45 $13,506 - $15,990	1,035 Added 4.04%	26,631 $397,000
Q1 2018 May 02, 2018	SELL	$12.0 - $14.45 $14,700 - $17,701	-1,225 Reduced 4.57%	25,596 $334,000
Q4 2017 Feb 09, 2018	SELL	$11.65 - $13.35 $55,931 - $64,093	-4,801 Reduced 15.18%	26,821 $338,000
Q3 2017 Nov 06, 2017	BUY	$11.95 - $13.35 $377,882 - $422,153	31,622	31,622 $410,000

Others Institutions Holding LNDC

# of Institutions

Shares Held

23.4M

Call Options Held

Put Options Held

11.9K

View Full List

About LANDEC CORP \CA\

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

More about LNDC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Landec Corp \Ca\ Transaction History